Bharat Biotech
-
WHO to decide on Bharat Biotech's Covaxin emergency usage in October
India | Sep 30, 2021, 02:39 PM ISTBharat Biotech had submitted EOI (Expression of Interest) on April 19 for its vaccine.
-
Paediatric Covaxin: Bharat Biotech completes phase 2/3 trials
India | Sep 21, 2021, 02:54 PM ISTCovaxin production would touch 55 million doses in October as against 35 million in September.
-
Bharat Biotech's Covaxin to get WHO nod this week, say sources
India | Sep 14, 2021, 03:45 PM ISTBharat Biotech's Covaxin will get approval from the World Health Organisation (WHO) this week, sources told news agency ANI.
-
Gujarat: First commercial batch of Covaxin released from Bharat Biotech's new plant
India | Aug 29, 2021, 01:20 PM ISTThe govt had earlier this month given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce anti-COVID vaccine Covaxin.
-
Covaxin single-dose to Covid infected equivalent to 2 doses for unaffected: ICMR
India | Aug 28, 2021, 02:39 PM ISTThe ICMR in its recent study has found that the people already infected with Covid-19 while taking a dose of Covaxin have the same or increased antibody response as unaffected people taking two doses of Covaxin.
-
India has done better than any country across world in vaccination: Bharat Biotech CMD Krishna Ella
India | Aug 15, 2021, 02:53 PM ISTIn his Independence Day speech from the ramparts of the Red Fort, PM Modi said India takes pride in having the world's largest vaccination programme, and over 54 crore people have already taken the COVID vaccines.
-
First Covid nasal vaccine by Bharat Biotech gets regulators nod for phase 2, 3 trials
India | Aug 13, 2021, 06:49 PM ISTThe first nasal vaccine against coronavirus developed by Bharat Biotech supported by Department of Biotechnology (DBT) and its PSU, Biotechnology Industry Research Assistance Council (BIRAC) has been given regulator's nod for conducting phase 2 and 3 trials, the Ministry of Science & Technology informed on Friday.
-
Covaxin production to get boost as govt approves manufacturing facility in Gujarat's Ankleshwar
India | Aug 10, 2021, 12:44 PM ISTThe Centre has approved a vaccine manufacturing facility for the production of Covaxin in Gujarat's Ankleshwar.
-
No compromise on Covaxin quality, says Bharat Biotech
India | Aug 05, 2021, 11:47 PM ISTThe vaccine maker stated that as of date, all batches of Covaxin were manufactured and released from its manufacturing facilities at Genome Valley, Hyderabad, which are fully audited and approved by regulatory authorities.
-
Covaxin receives GMP certificate from Hungary, says Bharat Biotech
India | Aug 05, 2021, 10:26 AM ISTThe approval received is from the National Institute of Pharmacy and Nutrition, Hungary certifying the GMP for the manufacture of Covaxin, a note posted on twitter said.
-
Bharat Biotech's Rotavac 5D receives WHO Prequalification
India | Aug 02, 2021, 05:36 PM ISTWHO Prequalification enables the procurement of Rotavac 5D by agencies such as UNICEF and PAHO (Pan American Health Organisation) and will fast-track global access to this life saving vaccine.
-
Covaxin effective against Delta Plus variant of Covid-19: ICMR Study
India | Aug 02, 2021, 01:36 PM ISTICMR reveals that Covaxin is effective against the Delta Plus variant of COVID 19.
-
WHO commences emergency use listing review process of Covaxin: Govt
India | Jul 27, 2021, 11:30 PM ISTResponding to a question on whether it has come to the notice of the government that Covaxin used in India is not recognised by many countries, Pawar said the government is aware that Covaxin at present is not part of WHO Emergency Use Listing (EUL).
-
'Very low' Covaxin stock, meagre supply of doses likely to hit inoculation: Bengal official
India | Jul 25, 2021, 06:26 AM ISTWest Bengal has vaccinated over 2.75 crore people so far and out of them, 81.9 lakh got the second dose, the health official said.
-
Covaxin trials for children underway; results by Sept: AIIMS chief
India | Jul 24, 2021, 01:11 PM ISTThe Government of India has been holding discussions with COVID-19 vaccine manufacturers Moderna and Pfizer, for procuring their vaccine. However, there has been a delay over the same.
-
CLAT 2021 exam analysis: 'Paper was moderately difficult'; check candidates, experts' reactions
Education | Jul 23, 2021, 10:02 PM ISTThe candidates found the Quantitative and Logical reasoning section a bit difficult, while sections like English, GK and Current Affairs were appeared to be easy.
-
Bharat Biotech terminates agreement with Brazilian partners after graft allegations
India | Jul 23, 2021, 11:47 PM ISTThe termination of the MoU came after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.
-
AIIMS Delhi to begin Covaxin second dose trial on 2-6 age group next week
India | Jul 23, 2021, 08:34 AM ISTTrials for coronavirus vaccine for children are underway in the country ahead of an anticipated third wave of the pandemic.
-
Bharat Biotech partner Ocugen seeks approval for Covaxin in Canada
India | Jul 16, 2021, 10:51 AM ISTThe rolling submission process was recommended and accepted under the Minister of Health's Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.
-
Dip in average daily vaccination against COVID-19 since June 21: Govt data
India | Jul 12, 2021, 01:55 PM ISTA decline in average daily vaccination against the coronavirus has been seen since June 21, when the new phase of universalisation of COVID-19 vaccination commenced, government data showed.